Company: Hanmi Science Company Limited
Bloomberg ticker: 008930 KS
Market cap: US$1,765m
Background: Hanmi Science Company Limited is a Korean holding company for the Hanmi Pharmaceutical Group. The business is focused on healthcare, specifically pharmaceutical R&D, manufacturing, and distribution. It is known for its innovative drugs in metabolic diseases (such as diabetes/obesity), oncology, and rare diseases. Korea and China are its largest markets.
World Class Benchmarking of Hanmi Science
Profitable Growth rank of 6 was up compared to the prior period’s 8th rank.
This is below average performance compared to 370 large Health Care companies worldwide.
Profitability rank of 5 was better than its Growth rank of 8.
Profitability rank of 5 was up compared to the prior period’s 6th rank.
This is average performance compared to peers.
Growth rank of 8 was up compared to the prior period’s 9th rank.
This is below average performance compared to peers
Comments
Log in or sign up to join the conversation.